Friends! In this video, I'm going to discuss 2 stocks that im buying in this market.
2 extracted signals · 2 resolved · 0 still active
The Patient InvestorIndependent analyst profile- Source published
- 05 Feb 2026, 00:16 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:24 UTC

AI-generated source summary
The speaker is bullish on Microsoft (MSFT) and Meta (META), believing both stocks are undervalued and poised for growth. For MSFT, the analysis focuses on historical P/E ratios and future growth projections, suggesting a target price of $844.77 with a potential 110% upside. For META, the speaker highlights strong revenue and user growth, coupled with a reasonable valuation, leading to a positive outlook. The speaker's investment strategy involves dollar-cost averaging into these positions during market downturns.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
The Patient Investor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

